PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-66.33%
Both yoy net incomes decline, with MRVL at -58.63%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-3.06%
Negative yoy D&A while MRVL is 10.18%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-160.50%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
182.05%
SBC growth well above MRVL's 2.63%. Michael Burry would flag major dilution risk vs. competitor’s approach.
2892.00%
Slight usage while MRVL is negative at -24003.82%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
2016.67%
AR growth well above MRVL's 201.99%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
145.95%
Some inventory rise while MRVL is negative at -408.57%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
277.60%
A yoy AP increase while MRVL is negative at -1727.80%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-43.16%
Both reduce yoy usage, with MRVL at -207.23%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-1044.00%
Negative yoy while MRVL is 900.79%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-9.73%
Both yoy CFO lines are negative, with MRVL at -73.59%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
36.00%
Some CapEx rise while MRVL is negative at -33.02%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
55.46%
Purchases well above MRVL's 39.38%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
194.30%
We have some liquidation growth while MRVL is negative at -5.77%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
86.88%
Investing outflow well above MRVL's 105.67%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
111.11%
Issuance growth of 111.11% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.